In vitro study of cricket chitosan’s potential as a prebiotic and a promoter of probiotic microorganisms to control pathogenic bacteria in the human gut
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Kipkoech et al_Foods_2021_Vol 10(10)_e2310
Final published version, 749 KB, PDF document
In this study, cricket chitosan was used as a prebiotic. Lactobacillus fermentum, Lactobacillus acidophilus, and Bifidobacterium adolescentis were identified as probiotic bacteria. Cricket chitin was deacetylated to chitosan and added to either De Man Rogosa and Sharpe or Salmonella/Shigella bacterial growth media at the rates of 1%, 5%, 10%, or 20% to obtain chitosan-supplemented media. The growth of the probiotic bacteria was monitored on chitosan-supplemented media after 6, 12, 24, and 48 h upon incubation at 37◦C. Growth of Salmonella typhi in the presence of probiotic bacteria in chitosan-supplemented media was evaluated under similar conditions to those of the growth of probiotic bacteria by measuring growth inhibition zones (in mm) around the bacterial colonies. All chitosan concentrations significantly increased the populations of probiotic bacteria and decreased the populations of pathogenic bacteria. During growth, there was a significant pH change in the media with all probiotic bacteria. Inhibition zones from probiotic bacteria growth supernatant against Salmonella typhi were most apparent at 16 mm and statistically significant in connection with a 10% chitosan concentration. This study suggests cricket-derived chitosan can function as a prebiotic, with an ability to eliminate pathogenic bacteria in the presence of probiotic bacteria.
Original language | English |
---|---|
Article number | 2310 |
Journal | Foods |
Volume | 10 |
Issue number | 10 |
Number of pages | 13 |
ISSN | 2304-8158 |
DOIs | |
Publication status | Published - 2021 |
Bibliographical note
Funding Information:
Financial support for CK came from DANIDA funded by the Ministry of Foreign Affairs Denmark (2013?2018) under the funding no 13-06KU GREEiNSECT project. VBM-R was supported by a grant from the National Research Foundation of Korea (NRF-2018R1A6A1A03024862) to Prof. Chuleui Jung of Andong National University?s Basic Science Research Program. Ethical approval for this study was issued by the Director of Mount Kenya University through Dr Francis W. Muregi of the university?s Ethics Review Committee (ERC) on 09/01/2017 under the number AG422-4492/2015 to Principal Investigator Carolyne Kipkoech.
Funding Information:
Acknowledgments: The authors wish to acknowledge the support they have received for this research via funds from by DANIDA through the GREEiNSECT project. The authors would also like to express their thanks to Hansen-Denmark through Promaco Limited, Kenya for the provision of probiotic bacterial cultures.
Funding Information:
Funding: Financial support for CK came from DANIDA funded by the Ministry of Foreign Affairs Denmark (2013–2018) under the funding no 13-06KU GREEiNSECT project. VBM-R was supported by a grant from the National Research Foundation of Korea (NRF-2018R1A6A1A03024862) to Prof. Chuleui Jung of Andong National University’s Basic Science Research Program. Ethical approval for this study was issued by the Director of Mount Kenya University through Dr Francis W. Muregi of the university’s Ethics Review Committee (ERC) on 09/01/2017 under the number AG422-4492/2015 to Principal Investigator Carolyne Kipkoech.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
- Chitin, Chitosan, Diet, Growth inhibition, Human gut bacteria, Pathogenic, Pre-and probiotics
Research areas
Number of downloads are based on statistics from Google Scholar and www.ku.dk
ID: 282527548